Abstract:Copy number variants (CNVs) are among the largest genetic variants, yet CNVs have not been effectively ascertained in most genetic association studies. Here we ascertained protein-altering CNVs from UK Biobank whole-exome sequencing data ( n = 468,570) using haplotype-informed methods capable of detecting subexonic CNVs and variation within segmental duplications. Incorporating CNVs into analyses of rare variants predicted to cause gene loss of function (LOF) identified 100 associations of predicted LOF variants with 41 quantitative traits. A low-frequency partial deletion of RGL3 exon 6 conferred one of the strongest protective effects of gene LOF on hypertension risk (odds ratio = 0.86 (0.82–0.90)). Protein-coding variation in rapidly evolving gene families within segmental duplications—previously invisible to most analysis methods—generated some of the human genome's largest contributions to variation in type 2 diabetes risk, chronotype and blood cell traits. These results illustrate the potential for new genetic insights from genomic variation that has escaped large-scale analysis to date.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **The impact of copy number variations (CNVs) on human phenotypes has not been fully studied, especially the impact in protein - coding genes.** Specifically, the paper aims to: 1. **Detect and identify rare protein - altering CNVs**: By using a method with haplotype information, CNVs affecting protein - coding are detected from the whole - exome sequencing data of the UK Biobank, including sub - exon - level CNVs and variations within segmental duplication regions. 2. **Evaluate the impact of CNVs on human phenotypes**: Incorporate these CNVs into the analysis to predict rare variants leading to loss - of - function (LOF) of genes and evaluate their associations with 41 quantitative traits. For example, it is found that the low - frequency partial deletion of exon 6 of the RGL3 gene significantly reduces the risk of hypertension (odds ratio \( \text{OR} = 0.86 (0.82–0.90) \)). 3. **Reveal the impact of CNVs in rapidly evolving gene families on complex diseases**: Especially those gene families located within segmental duplication regions, which were previously difficult to analyze by conventional methods. For example, a strong association is found between CNVs in the 7q22.1 region and the risk of type 2 diabetes and chronotype. 4. **Explore the impact of common coding copy number variations**: Develop new algorithms to analyze common coding CNVs, especially variations within segmental duplication regions, thereby revealing their impact on human health. For example, a strong association is found between CNVs in the FCGR3 gene family and basophil count. ### Summary Through an improved haplotype - information method, the paper detects and analyzes rare protein - altering CNVs on a large scale for the first time and reveals the extensive impact of these variants on multiple human phenotypes. This not only fills the gaps in previous studies but also provides new insights into the role of CNVs in complex diseases.

Protein-altering variants at copy number-variable regions influence diverse human phenotypes